Design, synthesis and evaluation of antiproliferative activity of fluorinated betulinic acid

Add time:07/23/2019    Source:sciencedirect.com

Betulinic acid (BA), a pentacyclic triterpenoid, exhibits broad spectrum antiproliferative activity, but generally with only modest potency. To improve BA’s pharmacological properties, fluorine was introduced as a single atom at C-2, creating two diastereomers, or in a trifluoromethyl group at C-3. We evaluated the impact of these groups on antiproliferative activity against five human tumor cell lines. A racemic 2-F-BA (compound 6) showed significantly improved antiproliferative activity, while each diastereomer exhibited similar effects. We also demonstrated that 2-F-BA is a topoisomerase (Topo) I and IIα dual inhibitor in cell-based and cell-free assays. A hypothetical mode of binding to the Topo I-DNA suggested a difference between the hydrogen bonding of BA and 2-F-BA to DNA, which may account for the difference in bioactivity against Topo I.

We also recommend Trading Suppliers and Manufacturers of 1-(2-CHLORO-6-FLUORO-BENZYL)-1H-[1,2,3]TRIAZOLE-4-CARBOXYLIC ACID (cas 106308-57-0). Pls Click Website Link as below: cas 106308-57-0 suppliers

Prev:Novel bioanalytical method for the quantification of Rufinamide (cas 106308-44-5) in mouse plasma and tissues using HPLC-UV: A tool to support pharmacokinetic studies
Next:Nickel(II)-catalyzed addition reaction of arylboronic acids to isatins)